Although ACE2 mRNA expression was lower in PBMCs from COVID-19 patients than in PBMCs from healthy volunteers, this does not result in a lower expression of the ACE2 protein on the total population of PBMCs. The gene discussed is ACE2; the disease is COVID-19.